Detalles de la búsqueda
1.
Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials.
Br J Dermatol
; 190(6): 836-845, 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38470171
2.
Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial.
Br J Dermatol
; 188(1): 22-31, 2023 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36689515
3.
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
Br J Dermatol
; 189(4): 392-399, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37279795
4.
Double-Blind, Placebo-Controlled Study of Onabotulinumtoxin A for the Treatment of Hailey-Hailey Disease.
J Drugs Dermatol
; 22(4): 339-343, 2023 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37026885
5.
Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus Panel.
J Drugs Dermatol
; 22(6): 588-593, 2023 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37276166
6.
Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial.
J Am Acad Dermatol
; 86(1): 77-85, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34343599
7.
Open-Label Cohort Study to Evaluate Efficacy and Safety of Application of Glycopyrronium Cloth, 2.4% for Palmar Hyperhidrosis.
J Drugs Dermatol
; 21(5): 488-495, 2022 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35533035
8.
Evidence Threshold for a Precision Medicine Test that Predicts Optimal Response to a Biologic Agent in Patients With Psoriasis: A Consensus Panel.
J Drugs Dermatol
; 21(6): 630-636, 2022 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35674756
9.
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
JAMA
; 328(11): 1073-1084, 2022 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36125472
10.
Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study.
J Am Acad Dermatol
; 85(1): 95-104, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32585278
11.
Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial.
J Am Acad Dermatol
; 82(6): 1314-1320, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32007513
12.
Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: A phase II, randomized, controlled, double-blinded trial.
J Am Acad Dermatol
; 82(6): 1321-1327, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32068049
13.
Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study.
Pediatr Dermatol
; 37(3): 490-497, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32147881
14.
Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials.
J Am Acad Dermatol
; 80(1): 128-138.e2, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30003988
15.
A Randomized, Vehicle-Controlled Phase 3 Study of Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses on the Upper Extremities.
Dermatol Surg
; 45(7): 890-897, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30640777
16.
Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis.
BMC Dermatol
; 19(1): 15, 2019 11 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31690295
17.
Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability
J Drugs Dermatol
; 18(12): 1218-1225, 2019 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31860209
18.
Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice
J Drugs Dermatol
; 18(2): 122-129, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30794360
19.
Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials
J Drugs Dermatol
; 18(8): 804-813, 2019 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31424712
20.
Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.
Pediatr Dermatol
; 36(1): 89-99, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30451318